Two Finnish SPARK projects were once again selected to one of the leading biotech and pharma investor event in Silicon Valley. DecoDerma (a tissue specific therapy for skin diseases) and Anison (a natural medication for human papillomavirus (HPV) associated warts) projects were selected to present at BIO SPARK Showcase event in digital Bio Investor Forum 2020.

Nordic SPARKees succeeded once again extremely well since two of the Norwegian SPARKees were also selected to present. Since BIO SPARK Showcase invites usually 10-12 projects from all over the world, this in once again strong proof of the top-notch competence that Nordic universities and hospitals represent. And it is not surprise that SPARK Finland and SPARK Norway work closely together and we participate actively in building our European program network.

We wish all presenting teams success and look forward to have more teams presenting in other events.